Lack of expression of ALK and CD30 in breast carcinoma by immunohistochemistry irrespective of tumor characteristics

CD30 is a member of the tumor necrosis factor family of cell surface receptors normally expressed in lymphocytes, as well as some lymphomas, but has been described in other malignancies. Anaplastic lymphoma kinase (ALK) is a tyrosine kinase receptor that belongs to the insulin receptor superfamily,...

Descripción completa

Detalles Bibliográficos
Autores principales: Nassif, Samer, El-Zaatari, Ziad M., Attieh, Michel, Hijazi, Maya, Fakhreddin, Najla, Aridi, Tarek, Boulos, Fouad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709128/
https://www.ncbi.nlm.nih.gov/pubmed/31393373
http://dx.doi.org/10.1097/MD.0000000000016702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709128/
https://www.ncbi.nlm.nih.gov/pubmed/31393373
http://dx.doi.org/10.1097/MD.0000000000016702

Ejemplares similares